Phillips-Medisize Invited to Join Sanofi at Partnerships in Drug Delivery

Phillips-Medisize Corp. representatives Bill Welch, Chief Technology Officer, and Janne Turunen, Program Manager, will be part of the Sanofi presentation at the Partnership Opportunities in Drug Delivery (PODD) in Boston, Massachusetts on October 5, 2015.

This content was submitted directly to this website by the supplier.

Phillips-Medisize Corp. representatives Bill Welch, Chief Technology Officer, and Janne Turunen, Program Manager, will be part of the Sanofi presentation at the Partnership Opportunities in Drug Delivery (PODD) in Boston, Massachusetts on October 5, 2015.

The PODD conference brings together leaders in the pharma/biotech industry for networking and presentations on the latest drug delivery technologies, as well as insights on delivery and formulation needs. The ultimate goal of the conference is to inspire innovation and advancement of drug development and delivery.

"We’re pleased to join Paul Jansen from Sanofi, along with Rob Veasey of DCA Design International, at the PODD session entitled ‘The SoloStar Injection Device: Foundation for a Versatile Platform.’ At Phillips-Medisize, our team of 450 engineers is actively engaged in the design, development and commercialization of a wide range of drug delivery platforms, from injector pens to inhalation devices to wearable infusers, all in partnership with leading global biopharma companies," said Bill Welch.

The PODD conference will use the Intercontinental Boston hotel, as its venue this year and Phillips-Medisize representatives will be available in the exhibit hall at Booth 46.

>>For more information, click here.

More in Home